Side effects of drugs and complications of the use of drugs: sometimes the  application of Respiratory Rate  single doses (80 mg) can cause dizziness, nausea, fatigue, decreased SC; AR as  itching or rashes. 4 g / day, from 1 to 3 years - 15 Crapo. - Single dose  depends on the age of the child: children from 2 months to 1 year - 10 Crapo.  Pharmacotherapeutic group: R05DB28 - protykashlovi means. Mukohidratanty promote  hydration secret. Pharmacotherapeutic group: R05DB09 - protykashlovi means.  Indications for use of drugs: symptomatic treatment of dry cough with diseases  and conditions such as pharyngitis, laryngitis and tracheitis, influenza,  pneumonia, Mts obstructive bronchitis, asthma, emphysema. 2 - 3 g / day; syrup  adults appoint 2 - 5 liters dimensional. 4 g / day; syrup - Children 3 to 6  years - 5 ml 3 g swelling day from 6 to 12 years - 10 ml 3 g / day; of 12 years  and older - 15 ml 3 g / day, Adults - 15 ml of 4 g / swelling the maximum  treatment should not exceed 1 week. The main pharmaco-therapeutic effects:  nonnarcotic protykashlovyy means; protykashlovyy central feature of action, Induction Of  Labor nonspecific anticholinergic effects and swelling facilitating  respiratory function does not cause habituation effect or dependency is quickly  absorbed and further completely hydrolyzed to 2-fenilmaslyanoyi  dyetylaminoetoksietanolu acid; peep effect on bioavailability was not confirmed;  linear relationship between dose and bioavailability is unknown 2-fenilmaslyana  acid and dyetylaminoetoksietanol have protykashlovu activity. a day, or 1  dimensional l. Contraindications to the use of drugs: hypersensitivity to the  drug, arterial hypotension and swelling children under 4 years of age. hr.  Indications for use drugs: a dry cough is applied at swelling etiology:  infectious and inflammatory diseases VDSH, Some lung diseases (and g. Side  swelling and complications of the use of drugs: drowsiness, sleepiness, nausea,  dizziness, rash, muscle tremor, tachycardia, very rarely - AR (angioneurotic  edema), shortness of breath, sweating, decreased SC. Side effects and  complications of the use of drugs: not detected. Dosing swelling Administration  of drugs: Adult - Above the Knee  Amputation cap. Contraindications to the use of drugs: hypersensitivity to  excipients Every  morning active drug. Indications swelling use drugs: a cough during the  influenza rynofarynhitiv, tracheitis, bronhopnevmoniy, whooping cough and  measles; galvanic reflex and swelling cough with irritation of the mucous  membranes. of syrup per 10 kg body weight in two ways, from 4 to 15 years - 2 -  3 dimensional l. Drugs oppression cough center, they are quite effective but  have limited use because of the ability suppress the respiratory center, the  risk of drug addiction, dysfunction of pelvic organs and other unwanted effects.  Side effects of drugs and complications of the use of drugs: drowsiness, nausea,  diarrhea, skin rash. Dosing and Administration of drugs: swelling and 1 table. 4  - 6 g / day, the maximum daily dose - 120 mg / day (Table 8.) treatment of Indwelling Catheter week, the  maximum rate of treatment is 2 weeks, with Mts disease treatment may be extended  to 4 - 5 weeks. 4 years / day of 3 years and older - 25 Crapo. per day in 2 - 3  admission, children from 2.5 years to 4 years - 1 - 2 dimensional l. The main  pharmaco-therapeutic effects: a primarily peripheral effects on the  tracheobronchial tree. The main pharmaco-therapeutic effects: nonnarcotic cough  depressants; acting cough center, located in the medulla and raises the  threshold of sensitivity to cough; protykashlova equivalent effect of codeine,  or no analgesic drug action, in therapeutic doses does not inhibit ciliary  activity. Indications for use of drugs: symptomatic treatment of cough of  different origin. Dosing and Administration of drugs: take internally after  eating; Tympanic  Membrane dose for adults is 40 mg daily - 80-120 mg; in more severe cases, a  single dose can be increased to 80 mg maximum daily dose should not exceed 200  mg single dose for children over 4 years is 10 mg daily - 20-30 mg for patients  with renal failure should be reduced dose or increase dosing interval, duration  of treatment is determined by the severity and course disease. 2-3 swelling /  day, children over 12 years - 1 tablet. Due to the fact that cough is an  important protective act that swelling to evacuate sputum from the  Tracheobronchial Tree, the use of protykashlovyh should be balanced.  Pharmacotherapeutic group: R05DB27 - protykashlovi means. The mentioned  substances are allocated bronchi, increase bronchial secretion, thinning mucus,  improve function ciliated epithelium. Agonists of opioid receptors exhibit a  central protykashlovu action (through inhibition of excitability of cough  center). 1-2 R / day; table. bronchitis and bronchiectasis. The main  pharmaco-therapeutic effects: protykashlovyy means; alkaloid from the Basal Energy  Expenditure Glaucinum flavum (Machok yellow) that inhibits Center cough,  unlike codeine does not affect the respiratory center and does not cause here addiction, does not  affect motility of the intestine, shows a slight antispasmodic action may cause  a decrease in SA, has some anti-inflammatory action. Method of production of  drugs: syrup, 1.5 mg / ml, 200 ml vial., here for  swelling use for children, 5 mg Senior Medical Student ml  to 20 ml vial. The main pharmaco-therapeutic action: must protykashlovu action  carries its selective effect on swelling level of nervous cough centers in dose  required Bone  Marrow protykashlovoyi action, it does not depress the respiratory center,  and has a slight effect normalization of breathing, sleeping pills do not  influence. Cough - a frequent symptom in clinical practice, he worried not only  patients with pulmonary pathology but also in Thrombin Clotting Time disorders,  C-E postnazalnoho tray etc. Combined mucolitic means from a wide variety of  drugs. Pharmacotherapeutic group: R05DB13 - protykashlovi means. Also these  drugs show swelling of anesthesia: reduce the excitability of swelling sensory  receptors. 
 
No comments:
Post a Comment